Here's How Moderna Is Ensuring Its Lead in the Coronavirus Vaccine Market
As you might have guessed (thanks to the headline of this article), I'm referring to Moderna (NASDAQ: MRNA) and its coronavirus vaccine. Clearly, Moderna investors have reason to cheer. Instead they're elements that show us how Moderna may stay ahead of rivals in this increasingly competitive market.